Evidence map›Paper›PMID 37175277›Full record

ArticleMolecules (Basel, Switzerland)2023

The Antileishmanial Activity of Eugenol Associated with Lipid Storage Reduction Rather Than Membrane Properties Alterations.

Kristelle Hughes, Thanh Binh Le, Patrick Van Der Smissen, Donatienne Tyteca, Marie-Paule Mingeot-Leclercq, Joëlle Quetin-Leclercq

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Molecular Mechanisms of Basil (Molecules (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
  4. Eugenol-Rich Essential Oil fromPharmaceuticals (Basel, Switzerland) · 2023
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Kristelle HughesPharmacognosy Research Group, Louvain Drug Research Institute, Université Catholique de Louvain, Avenue E. Mounier 72, B1.72.03, B-1200 Brussels, Belgium.ORCID 0000-0003-2511-7398
Thanh Binh LePharmacognosy Research Group, Louvain Drug Research Institute, Université Catholique de Louvain, Avenue E. Mounier 72, B1.72.03, B-1200 Brussels, Belgium.
Patrick Van Der SmissenCELL Unit and PICT Imaging Platform, de Duve Institute, Université Catholique de Louvain, Avenue Hippocrate 75, B1.75.05, B-1200 Brussels, Belgium.
Donatienne TytecaCELL Unit and PICT Imaging Platform, de Duve Institute, Université Catholique de Louvain, Avenue Hippocrate 75, B1.75.05, B-1200 Brussels, Belgium.ORCID 0000-0002-7334-2648
Marie-Paule Mingeot-LeclercqCellular and Molecular Pharmacology Unit (FACM), Louvain Drug Research Institute, Université Catholique de Louvain, Avenue E. Mounier 73, B1.73.05, B-1200 Brussels, Belgium.ORCID 0000-0002-2569-2619
Joëlle Quetin-LeclercqPharmacognosy Research Group, Louvain Drug Research Institute, Université Catholique de Louvain, Avenue E. Mounier 72, B1.72.03, B-1200 Brussels, Belgium.ORCID 0000-0002-2278-6206
UCLouvain · BEde Duve Institute · BE

Funding

F.S.R-FNRS T.0175.20UCL ARC 17.22.085Vietnamese Ministry of Education and Training 100/QĐ-496 BGDĐT
6 · The paper itself

Abstract

Leishmaniasis is a neglected tropical disease that still infects thousands of people per year throughout the world. The occurrence of resistance against major treatments for this disease causes a healthcare burden in low-income countries. Eugenol is a phenylpropanoid that has shown in vitro antileishmanial activity against

Indexed as

Antiprotozoal AgentsLeishmania mexicanaLeishmaniasisAmphotericin BEugenolHumansSterolsAmphotericin BAntiprotozoal AgentsEugenolSterolsacidocalcisomeseugenolLeishmanialipid dropletsmembrane fluiditymembrane permeabilitymode of action

Identifiers

PMID37175277
PMCPMC10179746
OpenAlexW4376630691

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.